UBS Group’s Morgan Creek - Exos Active SPAC Arbitrage ETF CSH Stock Holding History

UBS Group’s Portfolio CSH Stock Details CSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-806	Closed	-$20.6K	–	11217
2022 Q4	$20.6K	Sell	806 -290	-26%	-$7.16K	﹤0.01%	7624
2022 Q3	$27K	Sell	1,096 -92	-8%	-$2.28K	﹤0.01%	7027
2022 Q2	$29K	Buy	1,188 +1,088	+1,088%	+$27.1K	﹤0.01%	6454
2022 Q1	$3K	Buy	+100	New	+$2.5K	﹤0.01%	9555

Other funds holding CSH

LFASL

Lugano Financial Advisors SA (LFA) Lugano, Switzerland $197M AUM 14.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group's CSH Position: Q1 2023 in Review

UBS Group sold out of Morgan Creek - Exos Active SPAC Arbitrage ETF (CSH) in Q1 2023, closing a stake of 806 shares — an estimated $20.6K sold.

UBS Group first reported a position in CSH in Q1 2022 and held it in 4 quarters. The position peaked at $29K in Q2 2022. 2 funds tracked by Wall St. Rank hold CSH as of Q1 2023.

UBS Group reported no remaining Morgan Creek - Exos Active SPAC Arbitrage ETF position as of Q1 2023 after selling out during the quarter.
UBS Group sold 806 Morgan Creek - Exos Active SPAC Arbitrage ETF shares in Q1 2023, an estimated $20.6K.
UBS Group first reported a position in Morgan Creek - Exos Active SPAC Arbitrage ETF in Q1 2022 and held it in 4 quarters.
UBS Group's Morgan Creek - Exos Active SPAC Arbitrage ETF position peaked at $29K in Q2 2022.
2 funds tracked by Wall St. Rank held Morgan Creek - Exos Active SPAC Arbitrage ETF as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.